000 | 01950 a2200601 4500 | ||
---|---|---|---|
005 | 20250517055117.0 | ||
264 | 0 | _c20151224 | |
008 | 201512s 0 0 eng d | ||
022 | _a0946-1965 | ||
024 | 7 |
_a10.5414/CP202424 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMandic, Dario | |
245 | 0 | 0 |
_aVKORC1 gene polymorphisms and adverse events in Croatian patients on warfarin therapy. _h[electronic resource] |
260 |
_bInternational journal of clinical pharmacology and therapeutics _cNov 2015 |
||
300 |
_a905-13 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
650 | 0 | 4 | _aCroatia |
650 | 0 | 4 |
_aDrug Monitoring _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Frequency |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aHemorrhage _xchemically induced |
650 | 0 | 4 | _aHeterozygote |
650 | 0 | 4 | _aHomozygote |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInternational Normalized Ratio |
650 | 0 | 4 | _aLinkage Disequilibrium |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPharmacogenetics |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aProthrombin Time |
650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVitamin K Epoxide Reductases _xgenetics |
650 | 0 | 4 |
_aWarfarin _xadministration & dosage |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aBozina, Nada | |
700 | 1 | _aMandic, Sanja | |
700 | 1 | _aSamardzija, Marina | |
700 | 1 | _aMilostic-Srb, Andrea | |
700 | 1 | _aRumora, Lada | |
773 | 0 |
_tInternational journal of clinical pharmacology and therapeutics _gvol. 53 _gno. 11 _gp. 905-13 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.5414/CP202424 _zAvailable from publisher's website |
999 |
_c25333032 _d25333032 |